Evaluation of commercial rapid lateral flow tests, alone or in combination, for SARS-CoV-2 antibody testing
- Peter U. Fischer
- , Kerstin Fischer
- , Kurt C. Curtis
- , Yuefang Huang
- , Nicole Fetcho
- , Charles W. Goss
- , Gary J. Weil
- Division of Infectious Diseases
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- Institute of Clinical and Translational Sciences (ICTS)
- Institute for Informatics, Data Science and Biostatistics (I2DB)
- Bursky Center for Human Immunology and Immunotherapy
- COVID-19 Researchers
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- DBBS - Evolution, Ecology and Population Biology
- Center for Biostatistics and Data Science (CBDS)
- DBBS - Biomedical Informatics and Data Science
Research output: Contribution to journal › Article › peer-review
11
Link opens in a new tab
Scopus
citations